American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000:6-10.
Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction: is there
evidence for an increased risk for women? Circulation.1995;91:1861-1871.
Bell DM, Nappi J. Myocardial infarction in women: a critical appraisal of gender differences
in outcomes. Pharmacotherapy.2000;20:1034-1044.
White HD, Barbash GI, Modan M.
et al. for the Investigators of the International Tissue Plasminogen Activator/Streptokinase
Mortality Study. After correcting for worse baseline characteristics, women treated
with thrombolytic therapy for acute myocardial infarction have the same mortality
and morbidity as men except for a higher incidence of hemorrhagic stroke. Circulation.1993;88:2097-2103.
Lincoff AM, Califf RM, Ellis SG.
et al. for the Thrombolysis and Angioplasty in Myocardial Infarction Study
Group. Thrombolytic therapy for women with myocardial infarction: is there
a gender gap? J Am Coll Cardiol.1993;22:1780-1787.
Becker RC, Terrin M, Ross R.
et al. for the Thrombolysis in Myocardial Infarction Investigators. Comparison of clinical outcomes for women and men after acute myocardial
infarction. Ann Intern Med.1994;120:638-645.
Weaver WD, White HD, Wilcox RG.
et al. for the GUSTO-I Investigators. Comparisons of characteristics and outcomes among women and men with
acute myocardial infarction treated with thrombolytic therapy. JAMA.1996;275:777-782.
Malacrida R, Genoni M, Maggioni AP.
et al. for the Third International Study of Infarct Survival Collaborative
Group. A comparison of the early outcome of acute myocardial infarction in
women and men. N Engl J Med.1998;338:8-14.
Hochman JS, Tamis JE, Thompson TD.
et al. for the Global Use of Strategies to Open Occluded Coronary Arteries
in Acute Coronary Syndromes IIb Investigators. Sex, clinical presentation, and outcome in patients with acute coronary
syndromes. N Engl J Med.1999;341:226-232.
Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A. Acute myocardial infarction in women: contribution of treatment variables
to adverse outcome. Am Heart J.2000;140:740-746.
Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction:
biology or methodology? JAMA.1990;263:1092-1096.
Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction:
comparison with 4315 men. Circulation.1991;83:484-491.
Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization
early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med.1992;116:785-790.
Kostis JB, Wilson AC, Dowd OK.
et al. for the MIDAS Study Group. Sex differences in the management and long-term outcome of acute myocardial
infarction: a statewide study: Myocardial Infarction Data Acquisition System. Circulation.1994;90:1715-1730.
Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the
Scottish MONICA population of Glasgow 1985 to 1991: presentation, diagnosis,
treatment, and 28-day case fatality of 3991 events in men and 1551 events
in women. Circulation.1996;93:1981-1992.
Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence
for a sex-age interaction. Arch Intern Med.1998;158:2054-2062.
Barron HV, Bowlby LJ, Breen T.
et al. Use of reperfusion therapy for acute myocardial infarction in the United
States: data from the National Registry of Myocardial Infarction 2. Circulation.1998;97:1150-1156.
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM.for the National Registry of Myocardial Infarction 2 Participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med.1999;341:217-225.
Gottlieb S, Harpaz D, Shotan A.
et al. for the Israeli Thrombolytic Survey Group. Sex differences in management and outcome after acute myocardial infarction
in the 1990s: a prospective observational community-based study. Circulation.2000;102:2484-2490.
Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital discharge for myocardial
infarction. Ann Intern Med.2001;134:173-181.
Weaver WD, Simes RJ, Betriu A.
et al. Comparison of primary coronary angioplasty and intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review. JAMA.1997;278:2093-2098.
Schömig A, Kastrati A, Dirschinger J.
et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared
with tissue plasminogen activator in acute myocardial infarction. N Engl J Med.2000;343:385-391.
Brener SJ, Barr LA, Burchenal JEB.
et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa
blockade with primary angioplasty for acute myocardial infarction. Circulation.1998;98:734-741.
Neumann FJ, Blasini R, Schmitt C.
et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary
flow and left ventricular function after the placement of coronary-artery
stents in acute myocardial infarction. Circulation.1998;98:2695-2701.
Montalescot G, Barragan P, Wittenberg O.
et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for
acute myocardial infarction. N Engl J Med.2001;344:1895-1903.
Rogers WJ, Canto JG, Lambrew CT.
et al. Temporal trends in the treatment of over 1.5 million patients with
myocardial infarction in the US from 1990 through 1999: the National Registry
of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol.2000;36:2056-2063.
Vacek JL, Handlin LR, Rosamond TL, Beauchamp G. Gender-related differences in reperfusion treatment allocation and
outcome for acute myocardial infarction. Am J Cardiol.1995;76:226-229.
Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short- and long-term mortality for patients undergoing primary angioplasty
for acute myocardial infarction. J Am Coll Cardiol.2000;36:1194-1201.
Stone GW, Grines CL, Browne KF.
et al. Comparison of in-hospital outcome in men versus women treated by either
thrombolytic therapy or primary coronary angioplasty for acute myocardial
infarction. Am J Cardiol.1995;75:987-992.
Harrell Jr FE. Predicting Outcomes: Applied Survival Analysis and
Logistic Regression. Charlottesville: University of Virginia; 1997:290-296.
Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A. Differences in prognostic factors and outcomes between women and men
undergoing coronary artery stenting. JAMA.2000;284:1799-1805.
Vacek JL, Rosamond TL, Kramer PH.
et al. Sex-related differences in patients undergoing direct angioplasty for
acute myocardial infarction. Am Heart J.1993;126:521-525.
Antoniucci D, Valenti R, Moschi G.
et al. Sex-based differences in clinical and angiographic outcomes after primary
angioplasty or stenting for acute myocardial infarction. Am J Cardiol.2001;87:289-293.
Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes
in coronary heart disease mortality: 10-year results from 37 WHO MONICA project
populations: monitoring trends and determinants in cardiovascular disease. Lancet.1999;353:1547-1557.
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial
infarction: collaborative overview of early mortality and major morbidity
results from all randomised trials of more than 1000 patients. Lancet.1994;343:311-322.
French JK, Williams BF, Hart HH.
et al. Prospective evaluation of eligibility for thrombolytic therapy in acute
myocardial infarction. BMJ.1996;312:1637-1641.
Cho L, Marso SP, Bhatt DL, Topol EJ. Optimizing percutaneous coronary revascularization in diabetic women:
analysis from the EPISTENT trial. J Womens Health Gend Based Med.2000;9:741-746.
First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of
suspected acute myocardial infarction: ISIS-1. Lancet.1986;2:57-66.
Pfeffer MA, Braunwald E, Moye LA.
et al. for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left
ventricular dysfunction after myocardial infarction: results of the survival
and ventricular enlargement trial. N Engl J Med.1992;327:669-677.
Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year